Literature DB >> 2112746

Mutations that disrupt DNA binding and dimer formation in the E47 helix-loop-helix protein map to distinct domains.

A Voronova1, D Baltimore.   

Abstract

A common DNA binding and dimerization domain containing an apparent "helix-loop-helix" (HLH) structure was recognized recently in a number of regulatory proteins, including the E47 and E12 proteins that bind to the kappa E2 motif in immunoglobulin kappa gene enhancer. The effect of site-directed mutagenesis on E47 protein multimerization and DNA binding was examined. Mutations in either putative helix domain disrupted protein dimerization and DNA binding. No DNA binding was observed when mutations were introduced in the basic region, but these mutants were able to dimerize. These basic region mutants were not able to bind to DNA as heterodimers with the wild-type E47 proteins, demonstrating that two functional basic regions are required for binding to DNA. Therefore the basic region mutants are "transdominant."

Mesh:

Substances:

Year:  1990        PMID: 2112746      PMCID: PMC54189          DOI: 10.1073/pnas.87.12.4722

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  21 in total

1.  A new DNA binding and dimerization motif in immunoglobulin enhancer binding, daughterless, MyoD, and myc proteins.

Authors:  C Murre; P S McCaw; D Baltimore
Journal:  Cell       Date:  1989-03-10       Impact factor: 41.582

2.  lyl-1, a novel gene altered by chromosomal translocation in T cell leukemia, codes for a protein with a helix-loop-helix DNA binding motif.

Authors:  J D Mellentin; S D Smith; M L Cleary
Journal:  Cell       Date:  1989-07-14       Impact factor: 41.582

3.  MyoD1: a nuclear phosphoprotein requiring a Myc homology region to convert fibroblasts to myoblasts.

Authors:  S J Tapscott; R L Davis; M J Thayer; P F Cheng; H Weintraub; A B Lassar
Journal:  Science       Date:  1988-10-21       Impact factor: 47.728

4.  Myogenin, a factor regulating myogenesis, has a domain homologous to MyoD.

Authors:  W E Wright; D A Sassoon; V K Lin
Journal:  Cell       Date:  1989-02-24       Impact factor: 41.582

5.  Leucine repeats and an adjacent DNA binding domain mediate the formation of functional cFos-cJun heterodimers.

Authors:  R Turner; R Tjian
Journal:  Science       Date:  1989-03-31       Impact factor: 47.728

6.  Parallel association of Fos and Jun leucine zippers juxtaposes DNA binding domains.

Authors:  R Gentz; F J Rauscher; C Abate; T Curran
Journal:  Science       Date:  1989-03-31       Impact factor: 47.728

7.  daughterless, a Drosophila gene essential for both neurogenesis and sex determination, has sequence similarities to myc and the achaete-scute complex.

Authors:  M Caudy; H Vässin; M Brand; R Tuma; L Y Jan; Y N Jan
Journal:  Cell       Date:  1988-12-23       Impact factor: 41.582

8.  A novel human muscle factor related to but distinct from MyoD1 induces myogenic conversion in 10T1/2 fibroblasts.

Authors:  T Braun; G Buschhausen-Denker; E Bober; E Tannich; H H Arnold
Journal:  EMBO J       Date:  1989-03       Impact factor: 11.598

9.  Closely related transcripts encoded by the neurogenic gene complex enhancer of split of Drosophila melanogaster.

Authors:  C Klämbt; E Knust; K Tietze; J A Campos-Ortega
Journal:  EMBO J       Date:  1989-01       Impact factor: 11.598

10.  Sequence of the twist gene and nuclear localization of its protein in endomesodermal cells of early Drosophila embryos.

Authors:  B Thisse; C Stoetzel; C Gorostiza-Thisse; F Perrin-Schmitt
Journal:  EMBO J       Date:  1988-07       Impact factor: 11.598

View more
  119 in total

1.  Establishment of distinct MyoD, E2A, and twist DNA binding specificities by different basic region-DNA conformations.

Authors:  T Kophengnavong; J E Michnowicz; T K Blackwell
Journal:  Mol Cell Biol       Date:  2000-01       Impact factor: 4.272

2.  Impaired immune responses and B-cell proliferation in mice lacking the Id3 gene.

Authors:  L Pan; S Sato; J P Frederick; X H Sun; Y Zhuang
Journal:  Mol Cell Biol       Date:  1999-09       Impact factor: 4.272

3.  The REG1 gene product is required for repression of INO1 and other inositol-sensitive upstream activating sequence-containing genes of yeast.

Authors:  Q Ouyang; M Ruiz-Noriega; S A Henry
Journal:  Genetics       Date:  1999-05       Impact factor: 4.562

4.  A point mutation in the MyoD basic domain imparts c-Myc-like properties.

Authors:  M E Van Antwerp; D G Chen; C Chang; E V Prochownik
Journal:  Proc Natl Acad Sci U S A       Date:  1992-10-01       Impact factor: 11.205

5.  HEB, a helix-loop-helix protein related to E2A and ITF2 that can modulate the DNA-binding ability of myogenic regulatory factors.

Authors:  J S Hu; E N Olson; R E Kingston
Journal:  Mol Cell Biol       Date:  1992-03       Impact factor: 4.272

6.  BMP-2 decreases Mash1 stability by increasing Id1 expression.

Authors:  Francesc Viñals; Julia Reiriz; Santiago Ambrosio; Ramon Bartrons; Jose Luis Rosa; Francesc Ventura
Journal:  EMBO J       Date:  2004-08-19       Impact factor: 11.598

7.  Identification of cyclin D3 as a direct target of E2A using DamID.

Authors:  Siyuan Song; Jonathan Cooperman; Danielle L Letting; Gerd A Blobel; John Kim Choi
Journal:  Mol Cell Biol       Date:  2004-10       Impact factor: 4.272

8.  The Enhancer of split [E(spl)] locus of Drosophila encodes seven independent helix-loop-helix proteins.

Authors:  C Delidakis; S Artavanis-Tsakonas
Journal:  Proc Natl Acad Sci U S A       Date:  1992-09-15       Impact factor: 11.205

9.  The centromere and promoter factor 1 of yeast contains a dimerisation domain located carboxy-terminal to the bHLH domain.

Authors:  S J Dowell; J S Tsang; J Mellor
Journal:  Nucleic Acids Res       Date:  1992-08-25       Impact factor: 16.971

10.  An Id-related helix-loop-helix protein encoded by a growth factor-inducible gene.

Authors:  B A Christy; L K Sanders; L F Lau; N G Copeland; N A Jenkins; D Nathans
Journal:  Proc Natl Acad Sci U S A       Date:  1991-03-01       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.